Breast Cancer Clinical Trials

Showing 1501-1520 of 4,817 trials

Study of Nanrilkefusp Alfa Alone and With Pembrolizumab in Adult Patients With Advanced/Metastatic Solid Tumors

NCT04234113

A multicenter open-label phase 1/1b study to evaluate the safety and preliminary efficacy of nanrilkefusp alfa as monotherapy and in combination with pembrolizumab in patients with selected advanced/metastatic solid tumors

Thyroid CancerRenal Cell CarcinomaNon Small Cell Lung Cancer+16 more

SOTIO Biotech AG115 participantsStarted Jun 2019

New Haven, Connecticut, United States • Pittsburgh, Pennsylvania, United States • Houston, Texas, United States +9 more locations

RECRUITING

A Composite Assay for HER2-positive Early-stage Breast Cancer Management

NCT06762977

The goal of this observational study is to assess the prognostic value of a genomic classifier (S18) and its refined version (S\*) in women with early-stage HER2-positive breast cancer. The study aims to determine whether these tools can predict event-free (EFS) and disease-free survival (DFS) in patients treated with neoadjuvant and/or adjuvant trastuzumab-based therapies.

Breast Cancer Early Stage Breast Cancer (Stage 1-3)HER2

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano180 participantsStarted Nov 2024

Brindisi, Italy • Naples, Italy

Study of Nanrilkefusp Alfa Alone and With Pembrolizumab in Adult Patients With Advanced/Metastatic Solid Tumors

A Composite Assay for HER2-positive Early-stage Breast Cancer Management

Related Searches

RESET-BRAIN: REhabilitation of SleEp and CogniTive Impairment in BReast Cancer Survivors Using an App-based Intervention

A Pharmacokinetic and Randomized Trial of Neoadjuvant Treatment With Anastrozole Plus AZD0530 in Postmenopausal Patients With Hormone Receptor Positive Breast Cancer

Exercises Using Virtual Reality on Cancer Patients

Organoids Based Drug Sensitivity in Neoadjuvant Chemotherapy of Breast Cancer

Drug Sensitivity of Hydrothorax and Ascite Organoids from Breast Cancer

Integrated Testing Strategy for Simultaneous Detection of ESR-1 and GBRCA Mutations Via Liquid Biopsy in HR+/HER2- Metastatic Breast Cancer (mBC) Patients,

CtDNA Based MRD Testing for NAC Monitoring in TNBC

The Added Value of Contrast Enhanced Mammography to Standard Mammography in Assessing the Extent of DCIS

Percent Weight Change in the Medical Supplement Group of Early Breast Cancer

PECS Block vs. Multimodal Analgesia for Prevention of Persistent Postoperative Pain in Breast Surgery

Oral AMXT 1501 Dicaprate in Combination With IV DFMO

The EMBRACE Study The EMBRACE Study

Abemaciclib, Palbociclib or Dalpiciclib Combined with Endocrine Therapy As First-line Treatment in HR Positive, HER2 Negative Unresectable or Metastatic Breast Cancer

Alcohol and Breast Cancer (ABC) Trial

Hemopatch Implication After Axillary Dissection for Breast Cancer

Comparison of Axillary Sentinel Lymph Node Biopsy Versus no Axillary Surgery

Body Image and Physical Activity of Women with Breast Cancer

Assessing the Benefit of Art & Music Therapy on Quality of Life in Patients With Breast Cancer